David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center, shared on X:
“KALC conference Seoul, preceding WCLC Fred R. Hirsch opens session with the current therapeutic landscape in advanced NSCLC. Advances coming so fast at even more rapid pace.
Better keep your running shoes on to keep up!”
Other articles about KALC on OncoDaily.